Memantine and Selenium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Memantine (memantine) and Selenium (selenium). Common drug interactions include autism spectrum disorder among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Memantine and Selenium. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Memantine?

Memantine has active ingredients of memantine. It is often used in alzheimer's disease. eHealthMe is studying from 10,266 Memantine users. Check the latest studies of Memantine.

What is Selenium?

Selenium has active ingredients of selenium. It is often used in vitamin supplementation. eHealthMe is studying from 5,314 Selenium users. Check the latest studies of Selenium.

On Jul, 10, 2026

14 people who take Memantine and Selenium together, and have interactions are studied.

Memantine and Selenium drug interactions.

What are the common drug interactions of Memantine and Selenium, by gender? *:

female:

Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
Diarrhoea
Ear infection
Fungal infection
Gastric infection (infection of stomach)
Gastrointestinal viral infection (virus infection of gastrointestinal tract)
Haemorrhage (bleeding)
Influenza
Mouth ulceration (mouth ulcers)
Polyp

male:

Decreased appetite
Fatigue (feeling of tiredness)
Parkinson's disease
Spinal stenosis (narrowing of spinal column)
Loss of consciousness
Weight decreased
Neutropenia (an abnormally low number of neutrophils)
Productive cough
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Spinal column stenosis (narrowing of spinal column)

What are the common drug interactions of Memantine and Selenium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Decreased appetite
Fatigue (feeling of tiredness)
Parkinson's disease
Spinal stenosis (narrowing of spinal column)
Drug eruption (adverse drug reaction of the skin)
Loss of consciousness
Rash
Neutropenia (an abnormally low number of neutrophils)
Productive cough
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

Constipation: 6 people, 42.86%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 42.86%
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 4 people, 28.57%
Laxative Supportive Care: 4 people, 28.57%
Back Pain: 4 people, 28.57%
Blood Creatinine Increased: 4 people, 28.57%
Enlarged Prostate: 4 people, 28.57%
High Blood Pressure: 4 people, 28.57%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 4 people, 28.57%
Indigestion: 4 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Memantine and Selenium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously